Our companies are made up of insanely talented people driven to change the world — and many of them are hiring. If you have drive, expertise, and a taste for adventure, we wholeheartedly encourage your interest.
Locations
San Francisco, CA, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
51-200 employees
Stage
Series C+
founded in
2018
Frontier Medicines is a precision medicine company that has pioneered a proprietary discovery and development platform to develop medicines against disease-causing proteins previously considered undruggable. Utilizing chemoproteomics, covalent drug discovery, and machine learning, Frontier focuses on developing anti-cancer therapies, with its lead program being FMC-376, a dual inhibitor targeting KRASG12C mutations prevalent in various cancers. The company has a global partnership with Abb Vie to discover and develop novel therapies against oncology and immunology targets, aiming to broaden the therapeutic landscape and deliver breakthrough medicines for patients.
Something looks off?